Scott K. Heysell

Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA

Scott K. Heysell, Jane L. Moore, Suzanne Keller et al. · Emerging infectious diseases · 2010 · 155 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis

Devyani Deshpande, Jotam G. Pasipanodya, Stellah Mpagama et al. · Clinical Infectious Diseases · 2018 · 100 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis

Jan‐Willem C. Alffenaar, Tawanda Gumbo, Kelly E. Dooley et al. · Clinical Infectious Diseases · 2019 · 90 citations · Full text

Public Health, Pharmacokinetics, Pharmacology +17

Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis

Darwin J. Operario, Alexander F. Koeppel, Stephen Turner et al. · PLoS ONE · 2017 · 78 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Discordance across Several Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Single Laboratory

Sayera Banu, S. M. Mazidur Rahman, Md. Siddiqur Rahman Khan et al. · Journal of Clinical Microbiology · 2013 · 73 citations · Full text

Veterinary Medicine, Infectious Diseases, Antimicrobial Resistance +14